T
Tao Zhang
Researcher at Shandong University
Publications - 250
Citations - 4902
Tao Zhang is an academic researcher from Shandong University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 30, co-authored 210 publications receiving 3267 citations. Previous affiliations of Tao Zhang include Peking University & Chinese PLA General Hospital.
Papers
More filters
Journal ArticleDOI
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study.
Jing Huang,Jianming Xu,Chen Yun,Wu Zhuang,Yiping Zhang,Zhendong Chen,Jia Chen,Helong Zhang,Zuoxing Niu,Qingxia Fan,Lizhu Lin,Kangsheng Gu,Ying Liu,Yi Ba,Zhanhui Miao,Xiaodong Jiang,Ming Zeng,Jianhua Chen,Zhichao Fu,Lu Gan,Jun Wang,Xianbao Zhan,Tianshu Liu,Zhiping Li,Lin Shen,Yongqian Shu,Tao Zhang,Qing Yang,Jianjun Zou,Suxia Luo,Feng Peng,Gang Wu,Nong Xu,Lin Zhao,Dong Ma,Shukui Qin,Wei Ren,Enxiao Li,H. Lu,Yueyin Pan,Jianping Xiong,Ying Yuan,Yuxian Bai,Lei Chen,Yi Hu,Li Zhang,Yong Gao +46 more
TL;DR: Second-line camrelizumab significantly improved overall survival in patients with advanced or metastatic oesophageal squamous cell carcinoma compared with chemotherapy, with a manageable safety profile.
Journal ArticleDOI
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial.
Caicun Zhou,Gongyan Chen,Yunchao Huang,Jianying Zhou,Lizhu Lin,Jifeng Feng,Zhe-Hai Wang,Yongqian Shu,Jianhua Shi,Yi Hu,Qiming Wang,Ying Cheng,Fengying Wu,Jianhua Chen,Xiaoyan Lin,Yongsheng Wang,Jian-An Huang,Jiuwei Cui,Lejie Cao,Yunpeng Liu,Yiping Zhang,Yueyin Pan,Jun Zhao,LiPing Wang,Jianhua Chang,Qun Chen,Xiubao Ren,Wei Zhang,Yun Fan,Zhiyong He,Jian Fang,Kangsheng Gu,Xiaorong Dong,Tao Zhang,Wei Shi,Jianjun Zou +35 more
TL;DR: The primary endpoint was met at the interim analysis, showing a statistically significant and clinically meaningful improvement in progression-free survival with camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in all patients, supporting camrelIZumabplus carboplasin and pemberrexed as a first-line treatment option for Chinese patients with advanced non-squamous NSCLC.
Journal ArticleDOI
Identification of Potential Biomarkers for Ovarian Cancer by Urinary Metabolomic Profiling
Tao Zhang,Xiaoyan Wu,Chaofu Ke,Mingzhu Yin,Zhenzi Li,Lijun Fan,Wang Zhang,Haiyu Zhang,Falin Zhao,Xiao-Hua Zhou,Ge Lou,Kang Li +11 more
TL;DR: It is demonstrated that urinary metabolomics analysis by UPLC-QTOF/MS, performed in a minimally noninvasive and convenient manner, possessed great potential in biomarker discovery for EOC.
Journal ArticleDOI
Normalization and integration of large-scale metabolomics data using support vector regression
Xiaotao Shen,Xiaoyun Gong,Yuping Cai,Yuan Guo,Jia Tu,Hao Li,Tao Zhang,Jialin Wang,Fuzhong Xue,Zheng-Jiang Zhu +9 more
TL;DR: A machine learning algorithm-based method, support vector regression (SVR), for large-scale metabolomics data normalization and integration that can effectively remove the unwanted intra- and inter-batch variations, and is much better than other common normalization methods.
Journal ArticleDOI
Nut consumption in relation to cardiovascular disease risk and type 2 diabetes: a systematic review and meta-analysis of prospective studies
Donghao Zhou,Haibing Yu,Fang He,Kathleen Heather Reilly,Jingling Zhang,Shuangshuang Li,Tao Zhang,Baozhen Wang,Yuanlin Ding,Bo Xi +9 more
TL;DR: A higher consumption of nuts was associated with reduced risk of CAD and hypertension but not stroke or T2D, and large randomized controlled trials are warranted to confirm the observed associations.